Fore Genomics Foresite 360

Fore Genomics has launched Foresite 360, a whole-genome sequencing test for the screening of healthy newborns that is marketed to parents and can be ordered online. The test uses a saliva sample and screens for more than 300 genetic diseases that are manageable. It also looks for genetically determined responses to 40 medication types, according to the San Diego-based company.